全球制药解决方案,

本地可信的专业知识

I-Magix Aoli Co., Ltd. iyinkampani engaphansi kwe-ZHENLONG BIOTECHNOLOGY LIMITED

 futhi iyona yodwa egunyaziwe ngokomthetho ukungenisa nokusabalalisa imikhiqizo yezokwelapha ye-AOLI eKenya.

Funda Ngaphezulu

Uhlanga noMsebenzi

ZHENLONG ke a etlhopho e etletseng pele ya lifaele tsa biopharmaceutical lefatšeng

e ikemiseditseng ho ntlafatsa bophelo ba batho ka ho kopanya saense, theknoloji, le talenta. Ka ho sebelisana le Jiangsu Lianhuan Pharmaceuticals, pono ea rona ke ho ntlafatsa bolengba bophelo ka tharollo e ncha ea meriana.

Funda Ngaphezulu

50

IMIKHI

一般信息的连环

+

——

80

+

——

IZILAND

4

——

ISIBALO

20

+

——

USD INCOME

Milhiyoni

Million

China Main Bord Listed

Jiangsu Lianhuan Pharmaceutical Co., Ltd. yasungulwa ngoDisemba 1999. Yaphumelela ukufakwa ohlwini olukhulu ku-Shanghai Stock Exchange ngoMashi 2003. Isitoko sithi “Lianhuan Pharma” futhi ikhodi yesitoko ngu 600513.

R&D Izinsiza

I-Lianhuan Pharma yenze izinkundla ezimbili ze-R&D eNanjing  kanye neYangzhou ngokusekelwe esiteshini sabafundi abahloniphekile nesiteshini sodokotela, futhi yenze ubudlelwano obuhle bokubambisana kwezobuchwepheshe ne-Shanghai Institute of Pharmaceutical Research of Chinese Academy of Sciences kanye neChina Pharmaceutical University, njll.

China's Pharma companies 100 Top

I-Jiangsu Lianhuan Pharmaceutical Co., Ltd. ikhule yaba yibhizinisi likazwelonke lobuchwepheshe obuphezulu elihlanganisa i-R&D, ukukhiqiza nokumaketha, futhi imikhiqizo yayo ihlanganisa izinto eziphakathi kwezinto eziphilayo, ama-API amakhemikhali kanye namafomu emithi agqibelele amakhemikhali. Imali engenayo yonyaka yenkampani idlula i-RMB 2 billion.

Imikhiqizo Portfolio

Ikhono lemikhiqizo yenkampani liqukethe izigaba eziyisihlanu ezinkulu zokwelapha:

1. Urological System                              2. Antihistamines

3. Cardiovascular                                   4. Steroid Hormones

5. Antibiotic

Izitifiketi Zenkampani

AOLI 产品

Umkhiqizo1.jpg

AOLI Tadalafil 20mg

AOLI Dapoxetine Hydrochloride 30mg

Le seul inhibiteur de PDE 5 approuvé par la FDA améliore significativement

la fonction érectile et aide les patients à compléter leur vie sexuelle.

Izinto zokuqala ezitholakalayo zokwelapha ezilandelayo ezivunyelwe ku-primary PE kanye

ne-secondary PE emazweni amaningi ngaphandle kwe-United States.

QALA UKWENZA KABANZI IBHIZINISI LAKHO

NAMHLANJE

Xhumana nethimba lethu lokusekelwa kwamakhasimende uma uneminye imibuzo.

Silapha ukuzokusiza

IZINSIZO NENKXENYELO

admin@aoli-kenya.com